Olema Pharmaceuticals (OLMA) Other Non-Current Assets (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Other Non-Current Assets data on file, last reported at $16.5 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 38.37% year-over-year to $16.5 million in Q1 2026; TTM through Mar 2026 was $16.5 million, a 38.37% increase from a year earlier, with the FY2025 full-year figure at $16.8 million, up 112113.33% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $16.5 million, down from $16.8 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for OLMA reached as high as $16.8 million in Q4 2025 and fell as low as $15000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $8.2 million across 5 years, with a median of $8.1 million in 2023.
• Across the five-year window, Other Non-Current Assets tumbled 99.82% in 2024 and surged 112113.33% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $4.3 million in 2022, then surged by 91.51% to $8.1 million in 2023, then tumbled by 99.82% to $15000.0 in 2024, then jumped by 112113.33% to $16.8 million in 2025, then retreated by 2.0% to $16.5 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $16.5 million in Q1 2026, $16.8 million in Q4 2025, and $16.7 million in Q3 2025.